Literature DB >> 17671214

Guggulsterone-induced apoptosis in human prostate cancer cells is caused by reactive oxygen intermediate dependent activation of c-Jun NH2-terminal kinase.

Shivendra V Singh1, Sunga Choi, Yan Zeng, Eun-Ryeong Hahm, Dong Xiao.   

Abstract

Guggulsterone, a constituent of Indian Ayurvedic medicinal plant Commiphora mukul, causes apoptosis in cancer cells but the sequence of events leading to cell death is poorly understood. We now show that guggulsterone-induced cell death in human prostate cancer cells is caused by reactive oxygen intermediate (ROI)-dependent activation of c-Jun NH(2)-terminal kinase (JNK). Exposure of PC-3 and LNCaP cells to apoptosis inducing concentrations of guggulsterone resulted in activation of JNK and p38 mitogen-activated protein kinase (p38 MAPK) in both cell lines and activation of extracellular signal-regulated kinase 1/2 (ERK1/2) in LNCaP cells. The guggulsterone-induced apoptosis in PC-3/LNCaP cells was partially but statistically significantly attenuated by pharmacologic inhibition (SP600125) as well as genetic suppression of JNK activation. On the other hand, pharmacologic inhibition of p38 MAPK activation in PC-3 or LNCaP cells (SB202190) and ERK1/2 activation in LNCaP cells (PD98059) did not protect against guggulsterone-induced cell death. The guggulsterone treatment caused generation of ROI in prostate cancer cells but not in a normal prostate epithelial cell line (PrEC), which was also resistant to guggulsterone-mediated JNK activation. The guggulsterone-induced JNK activation as well as cell death in prostate cancer cells was significantly attenuated by overexpression of catalase and superoxide dismutase. In addition, guggulsterone treatment resulted in a decrease in protein level and promoter activity of androgen receptor in LNCaP cells. In conclusion, the present study reveals that the guggulsterone-induced cell death in human prostate cancer cells is regulated by ROI-dependent activation of JNK and guggulsterone inhibits promoter activity of androgen receptor.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17671214     DOI: 10.1158/0008-5472.CAN-07-0120

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  29 in total

1.  Diallyl trisulfide selectively causes Bax- and Bak-mediated apoptosis in human lung cancer cells.

Authors:  Dong Xiao; Yan Zeng; Eun-Ryeong Hahm; Young-Ae Kim; Suresh Ramalingam; Shivendra V Singh
Journal:  Environ Mol Mutagen       Date:  2009-04       Impact factor: 3.216

2.  Withaferin A causes FOXO3a- and Bim-dependent apoptosis and inhibits growth of human breast cancer cells in vivo.

Authors:  Silvia D Stan; Eun-Ryeong Hahm; Renaud Warin; Shivendra V Singh
Journal:  Cancer Res       Date:  2008-09-15       Impact factor: 12.701

3.  [Aspects of traditional Indian medicine (Ayurveda) in urology].

Authors:  J Mani; S Kumar; G J Dobos; A Haferkamp
Journal:  Urologe A       Date:  2012-12       Impact factor: 0.639

4.  Reactive oxygen species signaling in cancer: comparison with aging.

Authors:  Igor Afanas'ev
Journal:  Aging Dis       Date:  2010-02-20       Impact factor: 6.745

5.  Guggulsterone induces apoptosis of human hepatocellular carcinoma cells through intrinsic mitochondrial pathway.

Authors:  Juan-Juan Shi; Xiao-Li Jia; Mei Li; Ning Yang; Ya-Ping Li; Xin Zhang; Ning Gao; Shuang-Suo Dang
Journal:  World J Gastroenterol       Date:  2015-12-21       Impact factor: 5.742

6.  Guggulsterone inhibits human cholangiocarcinoma Sk-ChA-1 and Mz-ChA-1 cell growth by inducing caspase-dependent apoptosis and downregulation of survivin and Bcl-2 expression.

Authors:  Fei Zhong; Jing Yang; Zhu-Ting Tong; Liu-Liu Chen; Lu-Lu Fan; Fang Wang; Xia-Li Zha; Jun Li
Journal:  Oncol Lett       Date:  2015-06-19       Impact factor: 2.967

Review 7.  Dysregulation of apoptotic signaling in cancer: molecular mechanisms and therapeutic opportunities.

Authors:  Jessica Plati; Octavian Bucur; Roya Khosravi-Far
Journal:  J Cell Biochem       Date:  2008-07-01       Impact factor: 4.429

8.  Guggulsterone enhances head and neck cancer therapies via inhibition of signal transducer and activator of transcription-3.

Authors:  Rebecca J Leeman-Neill; Sarah E Wheeler; Shivendra V Singh; Sufi M Thomas; Raja R Seethala; Daniel B Neill; Mary C Panahandeh; Eun-Ryeong Hahm; Sonali C Joyce; Malabika Sen; Quan Cai; Maria L Freilino; Changyou Li; Daniel E Johnson; Jennifer R Grandis
Journal:  Carcinogenesis       Date:  2009-09-16       Impact factor: 4.944

9.  Guggulsterone modulates MAPK and NF-kappaB pathways and inhibits skin tumorigenesis in SENCAR mice.

Authors:  Sami Sarfaraz; Imtiaz A Siddiqui; Deeba N Syed; Farrukh Afaq; Hasan Mukhtar
Journal:  Carcinogenesis       Date:  2008-08-05       Impact factor: 4.944

10.  Bortezomib up-regulates activated signal transducer and activator of transcription-3 and synergizes with inhibitors of signal transducer and activator of transcription-3 to promote head and neck squamous cell carcinoma cell death.

Authors:  Changyou Li; Yan Zang; Malabika Sen; Rebecca J Leeman-Neill; David S K Man; Jennifer R Grandis; Daniel E Johnson
Journal:  Mol Cancer Ther       Date:  2009-07-28       Impact factor: 6.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.